Skip to main content

Pathogenesis and Therapy of Rheumatoid Arthritis

  • Conference paper
  • First Online:
Book cover Tissue-Specific Estrogen Action

Part of the book series: Ernst Schering Foundation Symposium Proceedings ((SCHERING FOUND,volume 2006/1))

Abstract

Rheumatoid arthritis is a chronic disabling disease affecting at least 1% of the population on a worldwide basis. Research aimed at understanding the pathogenesis of this disease led to the identification of TNFα as a major pro-inflammatory cytokine expressed in the inflamed joints of patients with rheumatoid arthritis. Subsequently, in vitro studies provided evidence to suggest that TNFα played an important role in driving the expression of additional pro-inflammatory cytokines, such as IL-1, GM-CSF, IL-6, and IL-8, in synovial cell cultures. Another important finding that confirmed the pathological significance of TNFα was that mice genetically engineered to overexpress TNFα spontaneously developed arthritis. Subsequently, the therapeutic effect TNFα blockade was tested in animal models prior to clinical trials in human patients, which provided unequivocal verification of the validity of TNFα as a therapeutic target. Anti-TNFα therapy is now accepted as a fully-validated treatment modality for rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Afuwape AO, Kiriakidis S, Paleolog EM (2002) The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol 17:961–72

    PubMed  CAS  Google Scholar 

  • Albano SA, Santana-Sahagun E, Weisman MH (2001) Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum 31:146–59

    Article  PubMed  CAS  Google Scholar 

  • Alvaro-Garcia JM, Zvaifler NJ, Brown CB, Kaushansky L, Firestein GS (1991) Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and TNFα. J Immunol 146:3365–3371

    Google Scholar 

  • Anonymous (1978) Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Royal College of General Practitioners' Oral Contraception Study. Lancet 1:569–571

    Google Scholar 

  • Ballara S, Taylor PC, Reusch P, Marme D, Feldmann M, Maini RN, Paleolog EM (2001) Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 44:2055–2064

    Article  PubMed  CAS  Google Scholar 

  • Banerjee S, Wei BY, Hillman K, Luthra HS, David CS (1988) Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J Immunol 141:1150–1154

    PubMed  CAS  Google Scholar 

  • Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115–1119

    Article  PubMed  CAS  Google Scholar 

  • Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M (1989) Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244–247

    Article  PubMed  CAS  Google Scholar 

  • Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, Matsushima K, Feldmann M (1990) Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 20:2141–2144

    Article  PubMed  CAS  Google Scholar 

  • Brennan FM, Gibbons DL, Cope AP, Katsikis P, Maini RN, Feldmann M (1995) TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action. Scand J Immunol 42:158–165

    Article  PubMed  CAS  Google Scholar 

  • Brennan P, Bankhead C, Silman A, Symmons D (1997) Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin Arthritis Rheum 26:817–823

    Article  PubMed  CAS  Google Scholar 

  • Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M (1988) Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin Exp Immunol 73:449–455

    PubMed  CAS  Google Scholar 

  • Butler DM, Maini RN, Feldmann M, Brennan FM (1995) Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 6:225–230

    PubMed  CAS  Google Scholar 

  • Buzas EI, Hollo K, Rubliczky L, Garzo M, Nyirkos P, Glant TT (1993) Effect of pregnancy on proteoglycan-induced progressive polyarthritis in BALB/c mice: remission of disease activity. Clin Exp Immunol 94:252–260

    Article  PubMed  CAS  Google Scholar 

  • Choy EH, Kinsley GH, Panayi GS (1998) Monoclonal antibody therapy in rheumatoid arthritis. Br J Rheumatol 37:484–490

    Article  PubMed  CAS  Google Scholar 

  • Chu CQ, Field M, Abney E, Zheng RQ, Allard S, Feldmann M, Maini RN (1991) Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction. Clin Exp Immunol 86:380–386

    Article  PubMed  CAS  Google Scholar 

  • Cohen S, Katsikis PD, Chu CQ, Thmssen H, Webb LMC, Maini RN, Londei M, Feldmann M (1995) High IL-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 38:946–952

    Article  PubMed  CAS  Google Scholar 

  • Cooper SM, Sriram S, Ranges GE (1988) Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol 141:1958–1962

    PubMed  CAS  Google Scholar 

  • Cope AP (2003) Exploring the reciprocal relationship between immunity and inflammation in chronic inflammatory arthritis. Rheumatology (Oxford) 42:716–731

    Article  CAS  Google Scholar 

  • Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M (1992) Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 35:1160–1169

    Article  PubMed  CAS  Google Scholar 

  • Cope AP, Londei M, Chu NR, Cohen SB, Elliott MJ, Brennan FM, Maini RN, Feldmann M (1994) Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest 94:749–760

    Article  PubMed  CAS  Google Scholar 

  • Da Silva JA, Spector TD (1992) The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 11:189–194

    Article  PubMed  CAS  Google Scholar 

  • Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, Maini RN (1992) Localization of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801–809

    Article  PubMed  CAS  Google Scholar 

  • Deroo BJ, Korach KS (2006) Estrogen receptors and human disease. J Clin Invest 116:561–570

    Article  PubMed  CAS  Google Scholar 

  • Drossaers-Bakker KW, Zwinderman AH, van Zeben D, Breedveld FC, Hazes JM (2002) Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis. Ann Rheum Dis 61:405–408

    Article  PubMed  CAS  Google Scholar 

  • Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277–285

    Article  PubMed  CAS  Google Scholar 

  • Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J, Woody JN (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumour necrosis factor α. Arthritis Rheum 36:1681–1690

    Article  PubMed  CAS  Google Scholar 

  • Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smollen JS, Leeb B, Breedfeld FC, Macfarlane JD, Bijl H, Woody JN (1994a) Treatment with a chimaeric monoclonal antibody to tumour necrosis factor α suppresses disease activity in rheumatoid arthritis: results of a multi-centre, randomised, double blind trial. Lancet 344:1105–1110

    Article  PubMed  CAS  Google Scholar 

  • Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN (1994b) Repeated therapy with a monoclonal antibody to tumour necrosis factor α in patients with rheumatoid arthritis. Lancet 344:1125–1127

    Article  PubMed  CAS  Google Scholar 

  • Feldmann M, Maini RN (2001) Anti-TNFα therapy in rheumatoid arthritis: what have we learned? Annu Rev Immunol 19:163–196

    Article  PubMed  CAS  Google Scholar 

  • Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 14:397–440

    Article  CAS  Google Scholar 

  • Feldmann M, Brennan F, Williams RO, Maini RN (2003) Definition of TNFα as a therapeutic target for rheumatoid arthritis. In: Moreland LW, Emery P (eds) TNFα inhibition in the treatment of rheumatoid arthritis. Martin Dunitz, London, pp 1–22

    Google Scholar 

  • Goldschmidt TJ, Holmdahl R (1991) Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 21:1327–1330

    Article  PubMed  CAS  Google Scholar 

  • Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF (1983) Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet ii:1111–1115

    Google Scholar 

  • Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC Jr (2003) Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144:4241–4249

    Article  PubMed  CAS  Google Scholar 

  • Harrison BJ, Silman AJ, Wiles NJ, Scott DG, Symmons DP (2001) The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 44:323–330

    Article  PubMed  CAS  Google Scholar 

  • Hasler F, van de Putte L, Baudin M, Lodin E, Durrwell L, McAuliffe T, van de Auwera P (1996) Chronic TNF neutralization (up to 1 year) by lenercept (TNFR 55 IgG1, Ro 45–2081) in patients with rheumatoid arthritis: results from open label extension of a double blind single-dose phase I study. Arthritis Rheum 39:S243

    Google Scholar 

  • Hermann JA, Hall MA, Maini RN, Feldmann M, Brennan FM (1998) Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum 41:1388–1397

    Article  PubMed  CAS  Google Scholar 

  • Hirahara F, Wooley PH, Luthra HS, Coulam CB, Griffiths MM, David CS (1986) Collagen-induced arthritis and pregnancy in mice: the effects of pregnancy on collagen-induced arthritis and the high incidence of infertility in arthritic female mice. Am J Reprod Immunol Microbiol 11:44–54

    PubMed  CAS  Google Scholar 

  • Hirohata S, Sakakibara J (1999) Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis. Lancet 353:1331

    Article  PubMed  CAS  Google Scholar 

  • Hopkins SJ, Meager A (1988) Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 73:88–92

    PubMed  CAS  Google Scholar 

  • Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP (2001) Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 60:223–227

    Article  PubMed  CAS  Google Scholar 

  • Janossy G, Panayi G, Duke O, Bofill M, Poulter LW, Goldstein G (1981) Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 2:839–842

    Article  PubMed  CAS  Google Scholar 

  • Jansson L, Holmdahl R (1989) Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. J Reprod Immunol 15:141–150

    Article  PubMed  CAS  Google Scholar 

  • Jansson L, Holmdahl R (1992) Oestrogen-induced suppression of collagen arthritis; 17β-oestradiol is therapeutically active in normal and castrated F1 hybrid mice of both sexes. Clin Exp Immunol 89:446–451

    Article  PubMed  CAS  Google Scholar 

  • Jansson L, Holmdahl R (2001) Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum 44:2168–2175

    Article  PubMed  CAS  Google Scholar 

  • Jansson L, Mattsson A, Mattsson R, Holmdahl R (1990) Estrogen induced suppression of collagen arthritis. V: Physiological level of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T-cell dependent immunity and stimulates polyclonal B-cell activity. J Autoimmun 3:257–270

    Article  PubMed  CAS  Google Scholar 

  • Jansson L, Olsson T, Holmdahl R (1994) Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol 53:203–207

    Article  PubMed  CAS  Google Scholar 

  • Karlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH (1999) A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 42:910–917

    Article  PubMed  CAS  Google Scholar 

  • Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031

    PubMed  CAS  Google Scholar 

  • Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H (1982) Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 79:3632–3636

    Article  PubMed  CAS  Google Scholar 

  • Londei M, Lamb JR, Bottazzo GF, Feldmann M (1984) Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639–641

    Article  PubMed  CAS  Google Scholar 

  • Londei M, Bottazzo GF, Feldmann M (1985) Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 228:85–89

    Article  PubMed  CAS  Google Scholar 

  • Malyak M, Swaney RE, Arend WP (1993) Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Arthritis Rheum 36:781–789

    Article  PubMed  CAS  Google Scholar 

  • Mathers D, Russell A (1990) Adjuvant arthritis in the rat during pregnancy. Clin Exp Rheumatol 8:289–292

    PubMed  CAS  Google Scholar 

  • Mattsson R, Mattsson A, Holmdahl R, Whyte A, Rook GA (1991) Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol 85:41–47

    Article  PubMed  CAS  Google Scholar 

  • Miotla J, Maciewicz R, Kendrew J, Feldmann M, Paleolog E (2000) Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 80:1195–1205

    Article  PubMed  CAS  Google Scholar 

  • Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM (1997a) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337:141–147

    Article  PubMed  CAS  Google Scholar 

  • Moreland LW, Heck LW, Koopman WJ (1997b) Biologic agents for treating rheumatoid arthritis. Arthritis Rheum 40:397–409

    Article  PubMed  CAS  Google Scholar 

  • Nelson JL, Ostensen M (1997) Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 23:195–212

    Article  PubMed  CAS  Google Scholar 

  • O'Garra A, Murphy K (1993) T-cell subsets in autoimmunity. Curr Opin Immunol 5:880–886

    Article  PubMed  Google Scholar 

  • Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41:1258–1265

    Article  PubMed  CAS  Google Scholar 

  • Piguet PF, Grau GE, Vesin C, Loetscher H, Gentz R, Lesslauer W (1992) Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510–514

    PubMed  CAS  Google Scholar 

  • Powrie F, Correa-Oliveira R, Mauze S, Coffman RL (1994) Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179:589–600

    Article  PubMed  CAS  Google Scholar 

  • Ranges GE, Sriram S, Cooper SM (1985) Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T. J Exp Med 162:1105–1110

    Article  PubMed  CAS  Google Scholar 

  • Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, Bresnihan B (1988) Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 31:956–963

    Article  PubMed  CAS  Google Scholar 

  • Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164

    PubMed  CAS  Google Scholar 

  • Sheehan KC, Ruddle NH, Schreiber RD (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 142:3884–3893

    PubMed  CAS  Google Scholar 

  • Shevach EM (2000) Regulatory T cells in autoimmmunity. Annu Rev Immunol 18:423–449

    Article  PubMed  CAS  Google Scholar 

  • Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4(Suppl 3):S265–S272

    Article  PubMed  Google Scholar 

  • Silman A, Kay A, Brennan P (1992) Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 35:152–155

    Article  PubMed  CAS  Google Scholar 

  • Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, Ollier WE (1993) Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32:903–907

    Article  PubMed  CAS  Google Scholar 

  • Sivakumar B, Harry LE, Paleolog EM (2004) Modulating angiogenesis: more vs less. JAMA 292:972–977

    Article  PubMed  CAS  Google Scholar 

  • Sumariwalla PF, Cao Y, Wu HL, Feldmann M, Paleolog EM (2003) The angiogenesis inhibitor protease-activated kringles 1–5 reduces the severity of murine collagen-induced arthritis. Arthritis Res Ther 5:R32–R39

    Article  PubMed  CAS  Google Scholar 

  • Symons JA, Wood NC, Di Giovine FS, Duff GW (1988) Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity IL-1 and IL-2 inhibition. J Immunol 141:2612–2618

    PubMed  CAS  Google Scholar 

  • Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, Feldmann M, Maini RN (2000) Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum 43:38–47

    Article  PubMed  CAS  Google Scholar 

  • Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA (1992) Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 89:7375–7379

    Article  PubMed  CAS  Google Scholar 

  • Todd I, Londei M, Feldmann M, Bottazzo GF (1985) Role of MHC class II molecules and of autoantigens in the pathogenesis of human autoimmune endocrine diseases. In: Milgrom F, Abeyounis CJ, Albini B (eds) Antibodies: protective, destructive and regulatory role. Karger, Basel, pp 66–76

    Google Scholar 

  • Van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS (2004) CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775–2785

    Article  PubMed  Google Scholar 

  • Waites GT, Whyte A (1987) Effect of pregnancy on collagen-induced arthritis in mice. Clin Exp Immunol 67:467–476

    PubMed  CAS  Google Scholar 

  • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253–259

    Article  PubMed  CAS  Google Scholar 

  • Whyte A, Waites GT (1987) Levels of serum amyloid P-component associated with pregnancy and collagen-induced arthritis in DBA/1 (H-2q) mice. J Reprod Immunoly 12:155–159

    Article  CAS  Google Scholar 

  • Williams RO, Whyte A (1989) A comparison of anti-type II collagen antibody titres and isotype profiles in pregnant and virgin DBA/1 mice with collagen- induced arthritis. J Reprod Immunol 15:229–239

    Article  PubMed  CAS  Google Scholar 

  • Williams RO, Feldmann M, Maini RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89:9784–9788

    Article  PubMed  CAS  Google Scholar 

  • Williams RO, Ghrayeb J, Feldmann M, Maini RN (1995) Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD. Immunology 84:433–439

    PubMed  CAS  Google Scholar 

  • Wooley PH, Dutcher J, Widmer MB, Gillis S (1993) Influence of a recombinant human soluble tumour necrosis factor receptor Fc fusion protein on type II collagen-induced arthritis in mice. J Immunol 151:6602–6607

    PubMed  CAS  Google Scholar 

  • Xu WD, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ (1989) Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 83:876–882

    Article  PubMed  CAS  Google Scholar 

  • Yoshino S, Cleland LG, Mayrhofer G (1991) Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the alpha/beta T cell antigen receptor. Arthritis Rheum 34:1039–1047

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Arthritis Research Campaign (ARC) of Great Britain.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. O. Williams .

Editor information

K. S. Korach T. Wintermantel

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag

About this paper

Cite this paper

Williams, R.O. (2007). Pathogenesis and Therapy of Rheumatoid Arthritis. In: Korach, K.S., Wintermantel, T. (eds) Tissue-Specific Estrogen Action. Ernst Schering Foundation Symposium Proceedings, vol 2006/1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/2789_2006_019

Download citation

  • DOI: https://doi.org/10.1007/2789_2006_019

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-49547-5

  • Online ISBN: 978-3-540-49548-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics